Evaluating COVID-19 Vaccines in the Era of Endemicity-Recency vs Reformulation
JAMA Intern Med
.
2024 Aug 1;184(8):940-942.
doi: 10.1001/jamainternmed.2024.1637.
Authors
Gopi S Mohan
1
,
Michael J Mina
2
3
,
Pierre O Ankomah
4
5
Affiliations
1
Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston.
2
eMed, Miami, Florida.
3
The Immune Observatory, Boston, Massachusetts.
4
Division of Infectious Diseases, Massachusetts General Hospital, Boston.
5
Harvard Medical School, Boston, Massachusetts.
PMID:
38913364
DOI:
10.1001/jamainternmed.2024.1637
No abstract available
MeSH terms
COVID-19 Vaccines*
COVID-19* / epidemiology
COVID-19* / prevention & control
Endemic Diseases / prevention & control
Humans
SARS-CoV-2*
Substances
COVID-19 Vaccines